HIV Infection in Homosexual and Bisexual Men
This trial is active, not recruiting.
|Sponsor||National Institute of Allergy and Infectious Diseases (NIAID)|
|Trial size||1100 participants|
|Trial identifier||NCT00046280, MACS|
This is a comprehensive observational study of HIV infection in homosexual and bisexual men.
|United States||No locations recruiting|
|Other countries||No locations recruiting|
hide locations and contact info
|Los Angeles, CA||Public Health Center||no longer recruiting|
|Chicago, IL||Howard Brown Health Center||no longer recruiting|
|Baltimore, MD||Johns Hopkins School of Public Health||no longer recruiting|
|Pittsburgh, PA||University of Pittsburgh School of Public Health||no longer recruiting|
Male participants at least 18 years old.
- HIV negative, or
- HIV positive and no history or current use of highly active antiretroviral therapy (HAART), or
- HIV positive HAART recipient with documentation of HAART initiation, no AIDS diagnosis prior to HAART initiation, and a CD4 cell count and HIV-1 RNA measurement within 6 months prior to first HAART use.
- Sexual intercourse with men or at least 5 male or female partners in the 5 years prior to enrollment.
- Injection drug use within 1 year of enrollment.
- Perinatally acquired HIV infection.
|Description||The Multicenter AIDS Cohort Study (MACS) provides important information about the changing nature of HIV-mediated disease progression, the impact of antiretroviral treatment, the nature of HIV pathogenesis, and viral and host genetic factors. This study will also assess the long-term patterns of therapy use and risk-taking behaviors. Patients will have study visits every 6 months. The visits will include interviews, specimen collection, and a physical examination.|
Call for more information